About Gomti Life Sciences
Gomti Life Sciences is a company based in Bengaluru (India) founded in 1977 was acquired by Advinus Therapeutics in February 2020. The company has 74 employees as of March 22, 2024. Gomti Life Sciences operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
- Headquarter Bengaluru, India
- Employees 74 as on 22 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Gomti Life Sciences India Private Limited
- Date of Incorporation 02 Sep, 2010
- Jurisdiction Bangaore, Karnataka, India
-
Annual Revenue
$77.67 (USD)-96.98as on Mar 31, 2023
-
Net Profit
-$235.3 (USD)98.18as on Mar 31, 2023
-
EBITDA
-$312.97 (USD)97.98as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
74
as on Mar 22, 2024
-
Acquired by
Advinus Therapeutics
(Feb 05, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Gomti Life Sciences
Detailed funding history for Gomti Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Gomti Life Sciences
Gomti Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Advinus Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Integrated drug discovery and development services are provided.
|
Locked | Locked | Locked |
Investor details for Gomti Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gomti Life Sciences
Investment portfolio details for Gomti Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gomti Life Sciences
Detailed financials for Gomti Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gomti Life Sciences Comparisons
Peer comparison for Gomti Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gomti Life Sciences
Gomti Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
|
| Locked | Locked | Locked |
Integrated drug discovery and preclinical development services are provided.
|
|
| Locked | Locked | Locked |
Fluorinated compounds are synthesized and manufactured customly for various industries.
|
|
| Locked | Locked | Locked |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
Detailed competitors of Gomti Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gomti Life Sciences
Complete news archive for Gomti Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gomti Life Sciences
Gomti Life Sciences was founded in 1977.
Gomti Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Mahendra Sharma is the current CEO of Gomti Life Sciences.
As of Mar 22, 2024, the latest employee count at Gomti Life Sciences is 74.
Annual revenue of Gomti Life Sciences is $77.67 as on Mar 31, 2023.
Founded in 1977, active pharmaceutical ingredients and intermediates are produced by Gomti Life Sciences in the pharmaceutical sector. Operations cover antihypertensives, tocolytics, hematology, and other categories, with manufacturing facilities in Bengaluru, India, certified under ISO 14001 and OHSAS 18001. Contract research, custom synthesis, and analytical services are also provided to support pharmaceutical development.
Gomti Life Sciences's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Gomti Life Sciences has 1 investor. Key investors include Advinus Therapeutics.